Cargando…

Common characteristics of open source software development and applicability for drug discovery: a systematic review

BACKGROUND: Innovation through an open source model has proven to be successful for software development. This success has led many to speculate if open source can be applied to other industries with similar success. We attempt to provide an understanding of open source software development characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Årdal, Christine, Alstadsæter, Annette, Røttingen, John-Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206459/
https://www.ncbi.nlm.nih.gov/pubmed/21955914
http://dx.doi.org/10.1186/1478-4505-9-36
_version_ 1782215440586506240
author Årdal, Christine
Alstadsæter, Annette
Røttingen, John-Arne
author_facet Årdal, Christine
Alstadsæter, Annette
Røttingen, John-Arne
author_sort Årdal, Christine
collection PubMed
description BACKGROUND: Innovation through an open source model has proven to be successful for software development. This success has led many to speculate if open source can be applied to other industries with similar success. We attempt to provide an understanding of open source software development characteristics for researchers, business leaders and government officials who may be interested in utilizing open source innovation in other contexts and with an emphasis on drug discovery. METHODS: A systematic review was performed by searching relevant, multidisciplinary databases to extract empirical research regarding the common characteristics and barriers of initiating and maintaining an open source software development project. RESULTS: Common characteristics to open source software development pertinent to open source drug discovery were extracted. The characteristics were then grouped into the areas of participant attraction, management of volunteers, control mechanisms, legal framework and physical constraints. Lastly, their applicability to drug discovery was examined. CONCLUSIONS: We believe that the open source model is viable for drug discovery, although it is unlikely that it will exactly follow the form used in software development. Hybrids will likely develop that suit the unique characteristics of drug discovery. We suggest potential motivations for organizations to join an open source drug discovery project. We also examine specific differences between software and medicines, specifically how the need for laboratories and physical goods will impact the model as well as the effect of patents.
format Online
Article
Text
id pubmed-3206459
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32064592011-11-03 Common characteristics of open source software development and applicability for drug discovery: a systematic review Årdal, Christine Alstadsæter, Annette Røttingen, John-Arne Health Res Policy Syst Research BACKGROUND: Innovation through an open source model has proven to be successful for software development. This success has led many to speculate if open source can be applied to other industries with similar success. We attempt to provide an understanding of open source software development characteristics for researchers, business leaders and government officials who may be interested in utilizing open source innovation in other contexts and with an emphasis on drug discovery. METHODS: A systematic review was performed by searching relevant, multidisciplinary databases to extract empirical research regarding the common characteristics and barriers of initiating and maintaining an open source software development project. RESULTS: Common characteristics to open source software development pertinent to open source drug discovery were extracted. The characteristics were then grouped into the areas of participant attraction, management of volunteers, control mechanisms, legal framework and physical constraints. Lastly, their applicability to drug discovery was examined. CONCLUSIONS: We believe that the open source model is viable for drug discovery, although it is unlikely that it will exactly follow the form used in software development. Hybrids will likely develop that suit the unique characteristics of drug discovery. We suggest potential motivations for organizations to join an open source drug discovery project. We also examine specific differences between software and medicines, specifically how the need for laboratories and physical goods will impact the model as well as the effect of patents. BioMed Central 2011-09-28 /pmc/articles/PMC3206459/ /pubmed/21955914 http://dx.doi.org/10.1186/1478-4505-9-36 Text en Copyright ©2011 Årdal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Årdal, Christine
Alstadsæter, Annette
Røttingen, John-Arne
Common characteristics of open source software development and applicability for drug discovery: a systematic review
title Common characteristics of open source software development and applicability for drug discovery: a systematic review
title_full Common characteristics of open source software development and applicability for drug discovery: a systematic review
title_fullStr Common characteristics of open source software development and applicability for drug discovery: a systematic review
title_full_unstemmed Common characteristics of open source software development and applicability for drug discovery: a systematic review
title_short Common characteristics of open source software development and applicability for drug discovery: a systematic review
title_sort common characteristics of open source software development and applicability for drug discovery: a systematic review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206459/
https://www.ncbi.nlm.nih.gov/pubmed/21955914
http://dx.doi.org/10.1186/1478-4505-9-36
work_keys_str_mv AT ardalchristine commoncharacteristicsofopensourcesoftwaredevelopmentandapplicabilityfordrugdiscoveryasystematicreview
AT alstadsæterannette commoncharacteristicsofopensourcesoftwaredevelopmentandapplicabilityfordrugdiscoveryasystematicreview
AT røttingenjohnarne commoncharacteristicsofopensourcesoftwaredevelopmentandapplicabilityfordrugdiscoveryasystematicreview